Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

902.90
USD
-27.77
(-2.98%)
45.15EPS
16.19P/E
78.42BMarket Cap
Jan 29Next Earn

Regeneron Pharmaceuticals, Inc. Documents

Q2 FY2021 · Earnings release

9 pages

Read Regeneron Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this earnings release
Create a free account to start reading

Full documents are included with Professional

Q2 FY2021 documents